A Federation of Korean Industries survey revealed that Korea’s 600 biggest businesses intend to increase spending 12.1% to an all-time high of KRW 140.8 trillion ($123.9 billion) in 2012. Facility spending is projected to grow 10.9% to make up 80% of total spending, and R&D spending is slated to grow 16.9% to account for 20%. […]
The financial crisis in Greece has made an already dire situation even more difficult for researchers. Greece receives €3 billion ($4 billion) annually in structural funds from the EU. But only about 5% of this amount, which constitutes the majority of the country’s national research funding, goes toward research. Last year, the European Commission reduced […]
The “Nature Publishing Index 2011 Asia-Pacific” reveals that Japan leads the region in the number of scientific publications. The Index encompasses articles, letters and brief communications published in Nature and its 17 research journals in the 12-month period prior to the Index’s March release. There were 856 scientific publications attributed to Asia Pacific in that […]
Firms responding to AusBiotech and Grant Thornton’s second annual Biotechnology Industry Position Survey plan to spend a collective $610 million on R&D this year. The survey, conducted in January, questioned 50 CEOs at Australian life science and biotech companies. Participating CEOs at 82% of firms anticipate that their businesses will expand this year. Although just […]
Four UK research councils—the Biotechnology and Biological Sciences Research Council (BBSRC), the Engineering and Physical Sciences Research Council (ESPRC), the Economic and Social Research Council and the Medical Research Council (MRC)—along with the Technology Strategy Board have released a report reviewing UK regenerative medicine research. The report details the 353 grants totaling £72.6 million ($115.1 […]
Founded in 2008, the Council for Scientific and Industrial Research’s Open Source Drug Discovery (OSDD) network utilizes crowdsourcing and open innovation to develop new drugs. Platforms like this are an essential alternative to drug firms for developing drugs for neglected diseases, said T. Balganesh, who spearheads OSDD’s drug development unit and is the former head […]
Nepal’s Department of Drug Administration (DDA) has requested that all Nepalese drug firms implement GMP standards issued by the World Health Organization by midmonth. Currently, 60% of Nepal’s 40 drug firms adhere to GMP regulations. Ensuring that all firms are compliant will allow Nepal to participate in the industry on a global scale, according to […]
Brazilian President Dilma Roussef has slashed Brazil’s science budget for the second year in a row. In February, the government announced a BRL 6.7 billion ($3.7 billion) science budget for 2012, which is 22% less than 2011’s budget. The government issued the cuts as part of its plan to decrease national spending by BRL 55 […]
India has announced its fiscal 2012 budget, which takes effect April 1. The budget for the Ministry of Science and Technology would increase 9.1% to INR 7,857.61 crore ($1.6 billion). Within the Ministry, the largest increase would be for the Department of Science and Technology’s budget, which is set to jump 10.3% to INR 2,873.2 […]
On March 29, DBV Technologies became the fourth health-related company to complete an IPO in France this year. France has reached a 20-year high for the number of health care companies completing IPOs in one quarter. DBV joins Adocia, EOS Imaging and Intrasense as health-related firms that have completed French IPOs this year. Despite the […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
